Association between serum gonadotropin level and insulin resistance-related parameters in Korean women with polycystic ovary syndrome

키워드

참고문헌 (34)

1. Kuzbari O, "Berek & Novak’s gynecology", pp.1075~1080 (2012), Lippincott Williams &Wilkins
2. Rotterdam ESHRE, "ASRM-Sponsored PCOS Consensus Workshop Group", Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, 2004, pp.81, 19~25
3. Carmina E, "Polycystic ovary syndrome(PCOS) : arguably the most common endocrinopathy is associated with significant morbidity in women", J Clin Endocrinol Metab, 84, pp.1897~1899 (1999)
4. Fritz MA, "Clinical gynecologic endocrinology and infertility", pp.501~518 (2011), Lippincott Williams & Wilkins
5. 이정렬, "여성 생식에서 Anti-Müllerian Hormone의 역할", Obstetrics & Gynecology Science, 52(3), pp.285~300 (2009), 대한산부인과학회
6. Hsu MI, "Inappropriate gonadotropin secretion in polycystic ovary syndrome", Fertil Steril, 91, pp.1168~1174 (2009)
7. Kubota T, "Update in polycystic ovary syndrome : new criteria of diagnosis and treatment in Japan", Reprod Med Biol, 12, pp.71~77 (2013)
8. Ehrmann DA, "Polycystic ovary syndrome", N Engl J Med, 352, pp.1223~1236 (2005)
9. Carmina E, "Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome", Fertil Steril, 82, pp.661~665 (2004)
10. Lin JF, "Exploration of the classification of polycystic ovarian syndrome", Zhonghua Fu Chan Ke Za Zhi, 41, pp.684~688 (2006)
11. Chae SJ, "Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women", Hum Reprod, 23, pp.1924~1931 (2008)
12. de Kat AC, "Anti-Mullerian hormone as a marker of ovarian reserve in relation to cardio-metabolic health: a narrative review", Maturitas, 80, pp.251~257 (2015)
13. La Marca A, "Mullerian-inhibiting substance in women with polycystic ovary syndrome : relationship with hormonal and metabolic characteristics", Fertil Steril, 82, pp.970~972 (2004)
14. Nardo LG, "The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome", Hum Reprod, 24, pp.2917~2923 (2009)
15. Chun S, "1-h postprandial glucose level is related to the serum anti-Mullerian hormone level in women with polycystic ovary syndrome", Gynecol Endocrinol, 31, pp.815~818 (2015)
16. 심아라, "다낭성난소증후군에서 성선자극호르몬 분비 이상과 임상적, 호르몬, 대사적 특성과의 연관성", Obstetrics & Gynecology Science, 54(11), pp.659~665 (2011), 대한산부인과학회
17. Arroyo A, "Inappropriate gonadotropin secretion in polycystic ovary syndrome:influence of adiposity", J Clin Endocrinol Metab, 82, pp.3728~3733 (1997)
18. Kim JJ, "Assessment of hirsutism among Korean women : results of a randomly selected sample of women seeking pre-employment physical check-up", Hum Reprod, 26, pp.214~220 (2011)
19. Waldstreicher J, "Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization", J Clin Endocrinol Metab, 66, pp.165~172 (1988)
20. Cho LW, "The LH", FSH ratio has little use in diagnosing polycystic ovarian syndrome, 2006, pp.43(Pt 3), 217~219
21. Minakami H, "Prolactin release in polycystic ovarian syndrome", Endocrinol Jpn, 35, pp.303~310 (1988)
22. Papaleo E, "Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome", Hum Reprod, 16, pp.2263~2266 (2001)
23. Wiser A, "Effect of high LH", FSH ratio on women with polycystic ovary syndrome undergoing in vitro maturation treatment, 2013, pp.58, 219~223
24. 전성욱, "Serum luteinizing hormone level and luteinizing hormone", follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome, 2014, pp.41(2), 86~91[DOI]
25. Sikka P, "Ultrasonography of the ovaries and its correlation with clinical and endocrine parameters in infertile women with PCOS", Int J Fertil Womens Med, 52, pp.41~47 (2007)
26. Carmina E, "Evidence for altered adipocyte function in polycystic ovary syndrome", Eur J Endocrinol, 152, pp.389~394 (2005)
27. Kurioka H, "Glucose intolerance in Japanese patients with polycystic ovary syndrome", Arch Gynecol Obstet, 275, pp.169~173 (2007)
28. Banaszewska B, "Incidence of elevated LH", FSH ratio in polycystic ovary syndrome women with normo-and hyperinsulinemia, 2003, pp.48, 131~134
29. Patel K, "Increased luteinizing hormone secretion in women with polycystic ovary syndrome is unaltered by prolonged insulin infusion", J Clin Endocrinol Metab, 88, pp.5456~5461 (2003)
30. American Diabetes Association, "Postprandial blood glucose", Diabetes Care, 24, pp.775~778 (2001), American Diabetes Association
31. Abdul-Ghani MA, "What is the best predictor of future type 2 diabetes?", Diabetes Care, 30, pp.1544~1548 (2007)
32. Abdul-Ghani MA, "Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes : results from the Botnia Study", Diabetes Care, 32, pp.281~286 (2009)
33. Chen H, "Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model", Diabetes, 54, pp.1914~1925 (2005)
34. Hrebicek J, "Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention", J Clin Endocrinol Metab, 87, pp.144~147 (2002)

관련 논문AI추천